Pain and sedation. Acute pain, not elsewhere classified
Conditions
Interventions
Intervention 1: Control group: Patients in this group will receive intravenous ketamine (darman-yab daru) at a dose of 1 mg/kg over 10 minutes before the start of surgery. Intervention 2: Intervention
Sponsors
Bojnourd University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Be a candidate for minor orthopedic surgery The American Society of Anesthesiologists physical status I-II No history of drug addiction. Participants with no known hypersensitivity to the intervention drugs
Exclusion criteria
Exclusion criteria: participants who had a history of severe cardiac disease participants who had a history of severe renal disease participants who had a history of severe systemic disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: Before the intervention, 5-minute intervals during the intervention, and after the intervention. Method of measurement: Visual Analog Score (VAS).;Sedation. Timepoint: Before the intervention, 5-minute intervals during the intervention, and after the intervention. Method of measurement: Ramsay Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Heart Rate. Timepoint: Before the intervention, 5-minute intervals during the intervention, and after the intervention. Method of measurement: Cardiac and respiratory monitoring.;Mean arterial pressure (MAP). Timepoint: Before the intervention, 5-minute intervals during the intervention, and after the intervention. Method of measurement: Cardiac and respiratory monitoring.;Arterial oxygen saturation (SpO2). Timepoint: Before the intervention, 5-minute intervals during the intervention, and after the intervention. Method of measurement: Cardiac and respiratory monitoring. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHossein Zeraati
Bojnourd University of Medical Sciences
Outcome results
None listed